Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial
Thursday, April 02, 2026Positive highlevel results from the EMERALD Phase III trial showed AstraZenecas Imfinzi durvalumab in combination with Imjudo tremelimumab lenvatinib and transarterial chemoembolisation TACE
Pharma Partnering Summit EU 2026 to Convene in Basel for Strategic BD&L Collaborations
Thursday, April 02, 2026The Pharma Partnering EU Summit will take place in Basel Switzerland on May bringing together global leaders in business development and licensing from pharmaceutical and biotech organizations
Pharma Partnering Summit US 2026 Returns to San Diego to Connect Global BD&L Leaders
Thursday, April 02, 2026The Pharma Partnering Summit PPS US is set to return to San Diego California on April uniting senior business development and licensing BDL professionals from the pharmaceutical and biotechnology sectors
Sino Biological ProPure™ Endotoxin-Free Proteins: The "Invisible Guardian" of Biopharmaceuticals
Thursday, April 02, 2026It may happen that after months of meticulous handling your cells suddenly exhibit unexplained behavior or in the middle of crucial pharmacodynamic studies your mouse models spontaneously develop
Insilico Medicine Announces Global R&D Collaboration with Lilly
Tuesday, March 31, 2026Insilico Medicine a clinicalstage biotechnology company powered by generative artificial intelligence AI and automation today announced a drug discovery collaboration with Eli Lilly and Company Lilly
Building the Future of Biotechnology — UK Biotech Day 2026
Thursday, March 26, 2026UK Biotech Day taking place on May will be held at the Radisson Hotel Conference Centre London Heathrow The event is set to spotlight the strength global relevance and collaborative spirit of the UKs biotechnology ecosystem
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
Thursday, March 26, 2026Alteogen Inc KOSDAQ announced today that it has entered into an exclusive license agreement with Biogen Inc for the development and commercialization of subcutaneous SC formulations of biologics utilizing ALTB powered by Alteogens Hybrozyme technolo...
GlycoNex Inc. and Nippon Kayaku Co., Ltd. Enter Collaboration to Advance Next-Generation ADC Candidate GNX201-ADC
Tuesday, March 24, 2026GlycoNex Inc a clinicalstage biotechnology company focused on the development of glycandirected cancer immunotherapies today announced that it has entered into a collaboration agreement with Nippon Kayaku Co Ltd Nippon Kayaku to advance GNXADC
Insitro and Bristol Myers Squibb Collaboration Expanded with Nomination of New Targets
Monday, March 23, 2026Insitro the AI therapeutics company built on causal biology today announced the expansion of its strategic collaboration with Bristol Myers Squibb NYSE BMY to advance a broadened portfolio of therapeutic programs for amyotrophic lateral sclerosis ALS
Dsm-firmenich launches ModulaSENSE® Bitter – a novel taste modulation technology to enhance drug palatability
Friday, March 20, 2026Dsmfirmenich a leading innovator in nutrition health and beauty announces the launch of a new technology ModulaSENSE Bitter designed to help pharmaceutical companies improve the taste of drugs and increase patient adherence This new te
